Asia Pacific Latent TB Detection Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Test (Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA)) and End User (Hospitals, Diagnostic Centers, Laboratories, and Others)

No. of Pages: 114    |    Report Code: TIPRE00024698    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Latent TB Detection Market

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Latent TB Detection Market – By Test

1.3.2        APAC Latent TB Detection Market – By End User

1.3.3        APAC Latent TB Detection Market – By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Latent TB Detection Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

5.           APAC Latent TB Detection Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Escalating Prevalence of Tuberculosis

5.1.2        Surging Government Initiatives to Promote Tuberculosis Detection

5.2         Market Restraints

5.2.1        Emergence of Multidrug Resistant Tuberculosis (MDR-TB)

5.3         Market Opportunities

5.3.1        Advent of Market in Emerging Economies

5.4         Future Trends

5.4.1        Burgeoning Advancements in Tuberculosis Diagnosis

5.5         Impact Analysis

6.           Latent TB Detection Market – APAC Analysis

6.1         APAC Latent TB Detection Market Revenue Forecast and Analysis

7.           APAC Latent TB Detection Market Analysis – By Test

7.1         Overview

7.2         APAC Latent TB Detection Market Share, by Test, 2019 and 2027 (%)

7.3         Tuberculin Skin Test (TST)

7.3.1        Overview

7.3.2        Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

7.4         Interferon Gamma Released Assay (IGRA)

7.4.1        Overview

7.4.2        Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.           APAC Latent TB Detection Market Analysis – By End User

8.1         Overview

8.2         APAC Latent TB Detection Market Share, by End User, 2019 and 2027 (%)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.4         Diagnostic Centers

8.4.1        Overview

8.4.2        Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.5         Laboratories

8.5.1        Overview

8.5.2        Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

9.           APAC Latent TB Detection Market Analysis and Forecasts To 2027 – Country Analysis

9.1         APAC: Latent TB Detection Market

9.1.1        Overview

9.1.2        APAC: Latent TB Detection Market, by Country, 2019 & 2027 (%)

9.1.3        China: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.1          China: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.3.2          China Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

9.1.3.3          China Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

9.1.4        Japan: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.1          Japan: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.4.2          Japan Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

9.1.4.3          Japan Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

9.1.5        India: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.1          India: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.5.2          India Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

9.1.5.3          India Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

9.1.6        South Korea: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          South Korea: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          South Korea Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

9.1.6.3          South Korea Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

9.1.7        Australia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Australia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Australia Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

9.1.7.3          Australia Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on APAC Latent TB Detection Market

10.1      APAC: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      QIAGEN

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      bioMerieux SA

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      F. HOFFMANN-LA ROCHE LTD.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      BD

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Abbott

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Oxford Immunotec Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Lionex GmbH

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      ARKRAY, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Serum Institute of India Pvt. Ltd.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             APAC Latent TB Detection Market – Revenue, and Forecast to 2027 (US$ Million)

Table 2.             China Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

Table 3.             China Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 4.             Japan Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

Table 5.             Japan Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 6.             India Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

Table 7.             India Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 8.             South Korea Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 9.             South Korea Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 10.          Australia Latent TB Detection Market, by Test– Revenue and Forecast to 2027 (USD Million)

Table 11.          Australia Latent TB Detection Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 12.          Organic Developments Done By Companies

Table 13.          Inorganic Developments Done By Companies

Table 14.          Glossary of Terms

LIST OF FIGURES

Figure 1.           APAC Latent TB Detection Market Segmentation

Figure 2.           APAC Latent TB Detection Market – By Country

Figure 3.           APAC Latent TB Detection Market Overview

Figure 4.           Tuberculin Skin Test (TST) Segment Held Largest Share of APAC Latent TB Detection Market

Figure 5.           India to Show Remarkable Growth During Forecast Period

Figure 6.           APAC PEST Analysis

Figure 7.           APAC Latent TB Detection Market Impact Analysis of Drivers and Restraint

Figure 8.           APAC Latent TB Detection Market – Revenue Forecast and Analysis

Figure 9.           APAC Latent TB Detection Market Share, by Test, 2019 and 2027 (%)

Figure 10.        APAC Tuberculin Skin Test (TST): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 11.        APAC Interferon Gamma Released Assay (IGRA): Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        APAC Latent TB Detection Market Share, by End User, 2019 and 2027 (%)

Figure 13.        APAC Hospitals: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14.        APAC Diagnostic Centers: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 15.        APAC Laboratories: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        APAC Others: Latent TB Detection Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        APAC: Latent TB Detection Market, by Key Country – Revenue (2019) (USD Million)

Figure 18.        APAC: Latent TB Detection Market, by Country, 2019 & 2027 (%)

Figure 19.        China: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 20.        Japan: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        India: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        South Korea: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Australia: Latent TB Detection Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Impact of COVID-19 Pandemic in APAC Country Markets

The List of Companies - Asia Pacific Latent TB Detection Market

  1. Abbott
  2. ARKRAY, Inc.
  3. BD
  4. bioMerieux SA
  5. F. HOFFMANN-LA ROCHE LTD.
  6. Lionex GmbH
  7. Oxford Immunotec Ltd
  8. QIAGEN     
  9. Serum Institute of India Pvt. Ltd.